investorscraft@gmail.com

Intrinsic ValueL'Air Liquide S.A. (AI.PA)

Previous Close157.94
Intrinsic Value
Upside potential
Previous Close
157.94

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

L'Air Liquide S.A. is a global leader in industrial and medical gases, operating across three key segments: Gas & Services, Engineering & Construction, and Global Markets & Technologies. The company serves diverse industries, including metals, chemicals, refining, healthcare, and electronics, through its comprehensive portfolio of gases, energy solutions, and technological innovations. Its Gas & Services segment, the largest revenue driver, provides essential gases like oxygen, nitrogen, and hydrogen, alongside energy-efficient solutions such as cogeneration plants. The healthcare division focuses on medical gases and home healthcare services, reinforcing its presence in the life sciences sector. L'Air Liquide maintains a strong competitive edge through its extensive global footprint, technological expertise, and long-term contracts with industrial clients, positioning it as a critical enabler of energy transition and industrial efficiency. The company's Engineering & Construction segment further enhances its market position by designing and building gas production plants for third parties, while its Global Markets & Technologies segment pioneers solutions for renewable energy and deep tech applications, including hydrogen refueling and biomethane production.

Revenue Profitability And Efficiency

L'Air Liquide reported revenue of €27.1 billion in FY 2023, with net income of €3.3 billion, reflecting a robust profitability margin. The company generated €6.3 billion in operating cash flow, demonstrating strong cash conversion capabilities. Capital expenditures of €3.5 billion highlight its ongoing investments in growth and operational efficiency, particularly in energy transition initiatives and healthcare expansion.

Earnings Power And Capital Efficiency

The company's diluted EPS of €5.74 underscores its earnings power, supported by stable demand across industrial and healthcare markets. L'Air Liquide's capital efficiency is evident in its ability to balance high-margin gas services with strategic investments in renewable energy and technology, ensuring long-term value creation for shareholders.

Balance Sheet And Financial Health

L'Air Liquide maintains a solid balance sheet with €1.9 billion in cash and equivalents, offset by total debt of €12.4 billion. Its prudent financial management and strong cash flow generation provide ample liquidity to service debt and fund growth initiatives, ensuring financial stability despite macroeconomic uncertainties.

Growth Trends And Dividend Policy

The company has consistently delivered growth through organic expansion and strategic acquisitions, particularly in hydrogen and healthcare. Its dividend policy remains shareholder-friendly, with a dividend per share of €3.3, reflecting a commitment to returning capital while reinvesting in high-return projects.

Valuation And Market Expectations

With a market capitalization of €106.1 billion and a beta of 0.72, L'Air Liquide is valued as a stable, low-volatility investment. The market anticipates sustained growth from its leadership in industrial gases and energy transition, though macroeconomic headwinds may temper near-term expectations.

Strategic Advantages And Outlook

L'Air Liquide's strategic advantages include its global scale, technological leadership, and diversified customer base. The outlook remains positive, driven by demand for clean energy solutions and healthcare services, though competitive pressures and regulatory changes pose potential risks. The company is well-positioned to capitalize on long-term trends in sustainability and industrial innovation.

Sources

Company filings, investor presentations, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount